Biotricity Partners with Another Leading Group Purchasing Organization

Biotricity Inc., a prominent medical diagnostic and consumer healthcare technology company, announced a partnership with a second Group Purchasing Organization (GPO) in the United States. This development significantly extends Biotricity's market reach, providing access to over half of the hospitals across the nation, equating to a network of over 3,000 hospitals. This expansion is marked by the firm's connection with two major GPOs, accounting for over $160 billion in purchasing power.

Dr. Waqaas Al-Siddiq, the Founder, Chairman, and CEO of Biotricity, explains this partnership as a milestone in the company's expansion and growth strategy. Highlighting the importance of GPOs in reducing healthcare expenses, the collaboration positions Biotricity for increased market access and growth, emphasizing their commitment to delivering cost-effective, high-quality care.

The partnership arrives at a crucial time as U.S. healthcare expenditures soared to $4.5 trillion in 2022, with expectations of further increases due to an aging population. GPOs play a critical role in streamlining purchasing processes and have been credited with saving the healthcare industry up to $55 billion annually. Biotricity's new affiliation signals its strategic positioning for substantial growth and enhanced delivery of healthcare solutions.

Investors and stakeholders are encouraged to visit Biotricity’s website for more information on its medical diagnostic and consumer healthcare technologies and its future financial prospects.